Dihydrolipoyl Transacetylase (DLAT) Peptide
DLAT
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN937613
Quick Overview for Dihydrolipoyl Transacetylase (DLAT) Peptide (ABIN937613)
Target
DLAT
(Dihydrolipoyl Transacetylase (DLAT))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- DVVSLATKAR EGKLQPHEFQ GGTFTISNLG MFGIKNFSAI INPPQACILA
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of DLAT antibody,
Alternative Names: DLAT control peptide, DLAT antibody Blocking Peptide, Anti-DLAT Blocking Peptide, Dihydrolipoamide S-Acetyltransferase Blocking Peptide, DLTA Blocking Peptide, PDC-E2 Blocking Peptide, PDCE2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
-
Background
- DLAT is dihydrolipoamide acetyltransferase, the E2 subunit of the mammalian pyruvate dehydrogenase complex of the inner mitochondrial membrane. Patients with primary biliary cirrhosis show autoantibodies to DLAT.
-
Molecular Weight
- 69 kDa
Target
-
You are here:
